Greg has over 25 years' experience in the healthcare industry and has 15 years' experience in chief executive level roles in hospitals and health services. He is a Director/Board Member of Melbourne Health (including The Royal Melbourne Hospital) and Chairs the Finance and Audit Committees.
He has been a Surveyor for the Australian Council on Healthcare Standards for over 14 years, is an Associate Fellow of the College of Health Services Executives and a Member of the Australian Institute of Company Directors. He has participated in a range of industry and government advisory committees.
He is Executive Sponsor of the National Diabetes Action Program for Diabetes Australia, and a member of the Executive Committee for the National Diabetes Services Scheme.
He was also appointed an Ambassador for the Victorian Government's "Go For Your Life" initiative, and is active in various health promotion campaigns targeting the dual epidemics of Type 2 diabetes and obesity.
Professor Locarnini is the Divisional Head, Research & Molecular Development (R&MD) at VIDRL as well as the Director, World Health Organisation (WHO) Collaborating Centre for Virus Reference and Research at VIDRL. Stephen has extensive experience in international expertise in viral hepatitis and antiviral chemotherapy. He is a member of International Scientific Advisory Boards of several leading pharmaceutical companies. He is a member of International Scientific Advisory Boards of several leading pharmaceutical companies and is currently Chairman of ACT-HBV™ (Advancing the Clinical Treatment of Hepatitis B Virus)
He participated in the development of consensus guidelines for the diagnosis, management and prevention of viral hepatitis type B for the European Association for the Study of the Liver (EASL), the Asian Pacific Association for the Study of the Liver (APASL) and the American Association for the Study of Liver Diseases (AASLD).
He has 190 publications in international refereed journals with numerous invited editorials and book chapters on hepatitis viruses and is an inventor of 11 patent and patent applications.
Formerly Chief Executive Officer with Beecham New Zealand, Jon joined Beecham’s marketing division in brand management and new product development working in South Africa, London, Australia and New Zealand. At age thirty, he was the youngest CEO in the Group and reluctantly left the company after his family decided to settle permanently in New Zealand.
Jon has held Directorships of both public and private companies with a focus in the bio-medical field. He has acted as adviser to both the Thai Government and the then newly elected Mandela Government in South Africa as Advisor to the Strategic Planning Council.
Jon brings a wealth of over thirty years international experience in the pharmaceutical and bio-medical arena ranging from private start up companies to multinational public corporations.
Tony is a qualified accountant and is currently an authorised representative of Falconer Bellomo & Company Ltd., a Melbourne based licensed securities dealer. He has over 26 years experience in the banking and stockbroking industry, both in Australia and overseas. He has held executive management positions with a number of major international banks in Australia, the United States and Asia. He is currently a director of an ASX listed company.
All material © Evivar Medical Pty. Ltd. All rights reserved